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Abstract
Background: Primary care physicians are caring for increasing numbers of persons with comorbid
chronic illness. Longitudinal information on health outcomes associated with specific chronic
conditions may be particularly relevant in caring for these populations. Our objective was to assess
the effect of certain comorbid conditions on physical well being over time in a population of
persons with chronic medical conditions; and to compare these effects to that of hypertension
alone.
Methods: We conducted a secondary analysis of 4-year longitudinal data from the Medical
Outcomes Study. A heterogeneous population of 1574 patients with either hypertension alone
(referent) or one or more of the following conditions: diabetes, coronary artery disease, congestive
heart failure, respiratory illness, musculoskeletal conditions and/or depression were recruited from
primary and specialty (endocrinology, cardiology or mental health) practices within HMO and fee-
for-service settings in three U.S. cities. We measured categorical change (worse vs. same/better)
in the SF-36® Health Survey physical component summary score (PCS) over 4 years. We used
logistic regression analysis to determine significant differences in longitudinal change in PCS
between patients with hypertension alone and those with other comorbid conditions and linear
regression analysis to assess the contribution of the explanatory variables.
Results: Specific diagnoses of CHF, diabetes and/or chronic respiratory disease; or 4 or more
chronic conditions, were predictive of a clinically significant decline in PCS.
Conclusions: Clinical recognition of these specific chronic conditions or 4 or more of a list of
chronic conditions may provide an opportunity for proactive clinical decision making to maximize
physical functioning in these populations.
Published: 07 September 2004
Health and Quality of Life Outcomes 2004, 2:47 doi:10.1186/1477-7525-2-47
Received: 04 June 2004
Accepted: 07 September 2004
This article is available from: http://www.hqlo.com/content/2/1/47
© 2004 Bayliss et al; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Health and Quality of Life Outcomes 2004, 2:47 http://www.hqlo.com/content/2/1/47
Page 2 of 8
(page number not for citation purposes)
Background
Comorbid chronic diseases are increasingly recognized as
a significant factor in declining health. Of the 125 million
Americans with chronic diseases, 48% are estimated to
have at least one comorbidity, and 62% of persons over
the age of 65 have two or more chronic illnesses.[1,2]
Approximately 25% of persons with chronic illness have
some limitation in activity and the percent of persons
with disability increases with increasing numbers of coex-
isting conditions.[2,3] As the population in the United
States ages, the number of persons with comorbid chronic
disease will increase substantially. Primary care physicians
will both provide and coordinate much of the care for this
population [4].
Primary care for persons with chronic medical conditions
differs from specialist care for these same conditions in
the need to see both the forest and the trees: to address
disease-specific issues and outcomes in the context of
both coexisting medical conditions and the patient's psy-
chosocial environment. To this end, practice guidelines
developed from randomized controlled trials with strict
inclusion criteria may not generalize well to the heteroge-
neity of primary care practice or the complex individual
patient.
In the environment of competing demands that character-
izes medicine in general, and primary care in particular;
information on health outcomes that can be inferred from
the medical record problem list may be particularly rele-
vant in clinical decision making for persons with multiple
chronic conditions. We chose to investigate the health
outcome of physical well being for several reasons: It is
relevant to both clinical and quality-of-life decision mak-
ing; and previous findings have demonstrated that differ-
ent combinations of chronic medical conditions have
been shown to be associated with type and/or severity of
disability [5,6].
Longitudinal studies suggest that the cumulative effect of
comorbid conditions is not simply additive: certain com-
binations of diseases may have a greater effect on out-
comes than others. Combinations of diabetes plus obesity
or heart disease [7], and arthritis plus diabetes, pulmo-
nary disease or obesity [8] were significantly more detri-
mental to measures of health outcomes than either
condition alone or in combination with other comorbid-
ities. In a review of multiple longitudinal studies on
comorbidity, Gijsen et al. found comorbidity to be a pre-
dictor of higher mortality, worse functional status,
decreased quality of life, and increased health care utiliza-
tion [9]. It is impractical for the primary care physician to
maintain an awareness of specific combinations of
chronic conditions that may characterize patients at risk
for functional decline. However recognizing certain
chronic medical conditions as potential 'red flags' for fur-
ther investigation would be useful.
We hypothesized that certain chronic diseases that often
occur as comorbidities may have a greater impact than
others on functional status outcomes over time. To
explore this question, we analyzed data from the Medical
Outcomes Study (MOS), a longitudinal study focusing on
the care and medical outcomes of patients with specific
common chronic conditions [10]. The MOS data have
been previously used to study comparative effects of
chronic conditions on physical well being over time [11-
14]. These investigations have included analyses of the
effects of anxiety disorder, varying levels of physical activ-
ity, and depression on health outcomes in the context of
multiple chronic diseases.[12,15,16] We used this impor-
tant data set to further explore the complexities of long-
term health outcomes in a heterogeneous group of
patients with comorbid chronic disease.
Our study used MOS data to investigate the relative effect
of six different common chronic conditions (diabetes,
coronary artery disease (CAD), congestive heart failure
(CHF), chronic respiratory disease, musculoskeletal dis-
ease and depression) on measures of physical well being
over the course of four years in patients with comorbidi-
ties. This data base is comprised of information from
respondents with certain chronic medical conditions.
There is no information on 'healthy' respondents without
any chronic conditions. Therefore we examined the rela-
tive effects of selected conditions relative to hypertension
alone. We examined the presence of a specified level of
decline in physical well being that had been verified to be
clinically significant, rather than a change in the PCS score
that might be statistically significant but of limited practi-
cal importance to patients. In addition, we analyzed the
effect of specific diagnoses in the context of the total dis-
ease burden in an effort to identify possible 'sentinel' con-
ditions that may specifically contribute to functional
decline for patients with multiple comorbidities.
Methods
Study design
The MOS was a four-year observational study that
included assessment of health outcomes of chronically ill
patients. Details of the study including design, sampling,
site selection and clinician recruitment have been previ-
ously published[10,16-18]
Study setting
MOS study sites were selected from three cities (Boston,
MA, Chicago, IL and Los Angeles, CA), from both primary
care (family practice and internal medicine) and specialty
(endocrinology, cardiology and mental health) practices,
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and from both managed care and fee-for-service payment
plans.
Sample and data collection
The original study sample consisted of patients with one
or more of five chronic "tracer" conditions (hypertension,
adult onset diabetes, myocardial infarction within the
past six months, congestive heart failure or depression)
approached during a visit with an MOS clinician during a
two-week period in 1986. Of the 28,257 patients origi-
nally approached, 20,232 agreed to participate. From this
group, patients were selected for follow up on the basis of
diagnosis and completion of baseline data collection, as
described elsewhere [18,19]. Of the 3589 patients selected
for follow-up, 2708 completed a baseline assessment, and
2235 were randomly selected for follow-up. Four-year fol-
low-up data were obtained for 1574 of these 2235 (70%).
For the current study, the chronic conditions of interest
(diabetes, CAD, CHF, chronic respiratory disease, muscu-
loskeletal conditions, and depression) were defined by
combining the original tracer diagnoses with additional
diagnoses determined by a structured medical history
interview conducted by a trained clinician [17]. For exam-
ple our category of CAD consists of persons with the orig-
inal tracer condition of myocardial infarction within the
past 6 months plus those with a history of angina, current
symptoms of angina, and myocardial infarction more
than one year ago. If information about a condition was
missing, an independently derived probability of each
diagnosis was substituted if the probability was at least
90%. The components of each of the main diagnoses are
listed in Table 1. We chose to analyze these conditions
based on their high prevalence as well as frequent assess-
ment in the literature on comorbidity and chronic disease
management.
The final sample included patients who had complete
baseline and four-year follow-up information (including
deaths), had completed a medical history questionnaire,
and had definitive diagnostic information on their origi-
nal tracer condition [17]. Patients from the longitudinal
sample who were lost to follow-up did not have signifi-
cant differences in initial health status from those who
remained in the sample, however patients lost to follow-
up tended to be younger and had lower income than
those remaining [17].
Outcome measures
We analyzed categorical change (worse versus same/bet-
ter) in SF-36® Health Survey (SF-36) physical component
summary (PCS) scores over four years. We chose this
dichotomous outcome to emphasize the clinical impor-
tance of anticipating functional decline in patients with
chronic medical conditions. Categorical change was
defined as a decrease of 6.5 or more points in PCS. This
was based on standards for PCS scores in which a change
of 6.5 points is outside the 95% confidence interval for
PCS scores. Longitudinal change norms for PCS classify
patients with +/- two standard errors of measurement
(SEM) as "better" or "worse" and those within two SEM as
"staying the same" [17,20]. Changes of 6.5 points or more
in PCS over time are clinically significant and correlate
with changes in health and mortality [17,20]. We also
assessed linear change in PCS scores over the four-year
period.
Statistical analysis
Based on published sample sizes specifically calculated to
detect differences in PCS between two groups using
repeated measures over time, our sample size was ade-
quate to detect a difference of five points in PCS with 80%
power (alpha = 0.05, two tailed test with an intertemporal
correlation of 0.70) [20]. As these published sample size
calculations were designed to detect a slightly smaller dif-
ference in PCS than we chose to examine (5.0 versus 6.5
points), our sample sizes should be more than adequate.
We used logistic regression to analyze the independent
effect of each main chronic disease on categorical change
(worse vs. same/better) in PCS relative to hypertension
alone adjusting for the effect of the other main diseases.
Logistic regression was again used to assess change in PCS
Table 1: Components of main disease categories
Main Disease Number (percent)a
Diabetes 359
Type 2 diabetes mellitus 319 (88.9)
Type 1 diabetes mellitus 40 (11.1)
CAD 425
Myocardial infarction within past 6 
months
76 (17.9)
History of angina 104 (24.5)
Current angina 233 (54.8)
Myocardial infarction more than one 
year ago
135 (31.8)
CHF 159
Respiratory disease 133
Asthma 42 (31.6)
Chronic obstructive pulmonary disease 95 (71.4)
Other lung disease 23 (17.3)
Musculoskeletal disease 684
Back pain 446 (65.2)
Musculoskeletal complaints 277 (40.5)
Hip impairment 55 (8.0)
Osteoarthritis 145 (21.2)
Rheumatoid arthritis 30 (4.4)
Depression 555
Diagnosed depression 260 (46.8)
Symptoms of depression 295 (53.2)
a) May sum to more than 100% due to coexisting conditions.
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over four years in patients with one, two, three or four or
more of the main chronic conditions relative to those
with hypertension alone.
Due to the selection criteria for the original MOS study
[10], the MOS data set does not include 'healthy' partici-
pants without any chronic conditions. Therefore we used
persons with hypertension alone, but none of the other
main chronic conditions, as the referent group for the
analysis. In one analysis, hypertension alone had an effect
on PCS that was comparable to the effect of aging in a
'healthy' population.[21,22] However another longitudi-
nal analysis has shown slightly increased odds of a decline
in health status over 2 years in patients with hypertension
alone relative to those with no chronic conditions. This
effect diminished with age [7].
We completed separate regressions to determine the effect
on PCS due to each of the main chronic conditions of
interest. In these models, the study population was
divided into those with hypertension alone (referent
group), those with the main chronic disease of interest
(with and without other conditions), and those with any
other of the main chronic conditions other than the condi-
tion of interest. Using similar modeling, linear regression
analysis was used to assess the relative contributions of
the explanatory variables. There were no significant inter-
actions between each of the main conditions and the total
number of conditions. As age has been shown to be asso-
ciated with functional outcomes in persons with comor-
bidities [23], we assessed categorical change in PCS by
number of comorbid conditions relative to hypertension
alone for older and younger age groups (under 65 years
vs. 65 and over). Four-year change in PCS relative to
hypertension was comparable in both age groups, there-
fore the final analysis was not stratified by age.
Analyses were additionally adjusted for age, a count from
a list of 16 additional chronic conditions (in addition to
adjustments for main diseases as mentioned above), pov-
erty level, gender, race, educational level, employment
status, and marital status. Subjects who died during the
course of the study were assigned a four-year PCS score of
zero and included in the 'worse' category. Assignment of a
zero PCS sore to participants who died during the course
of the study has been discussed by Diehr et al. as a reason-
able approach for analyses in which a decline in health is
the outcome of interest [17,24]. Failure to incorporate
these subjects could substantially bias the results by limit-
ing the assessment of outcomes to 'healthier' subjects. To
partially account for level of physical well being at base-
line, the analyses also adjusted for starting PCS score rela-
tive to age/gender norms.
Results
Of a total of 1574 subjects, 281 individuals carried a diag-
nosis of hypertension exclusive of any of the other major
comorbid conditions, and were defined as the referent
population for this analysis. (As participants in the origi-
nal MOS study were selected on the basis of chronic med-
ical diagnoses, the study population did not include a
referent 'disease-free' population.) The remaining 1293
subjects had either one or more of the six comorbid con-
ditions of diabetes, CAD, CHF, respiratory disease, musc-
uloskeletal disease and depression with or without
hypertension. In this heterogeneous population, subjects
with the main conditions of interest had, on average, 1.8
of the main conditions and 0.8 from a list of 16 additional
conditions. Referent subjects with hypertension and no
other main conditions of interest had 0.3 additional con-
ditions. The majority of all respondents had starting PCS
scores within 1 standard deviation of age/gender norms,
with an additional 10% above and 26% below age gender
norms. Table 2 describes the characteristics of the study
population.
Table 2: Characteristics of study population
N 1574
Age (mean) +/- SD 57.6 +/- 15.4
Male 41.3%
Married 58.3%
Employed 46.4%
At or below 200% of poverty level 19.3%
White (vs. non-white) 82.5%
Education
Education less than high school 14.6%
High School graduate 28.5%
Greater than high school 28.5%
College graduate 12.1%
Greater than college 16.3%
Mean number of main diseases* 1.5
Hypertension alone (referent group) 0
Remaining subjects 1.8
Mean number of additional diseases** 0.7
Hypertension alone (referent group) 0.3
Remaining subjects 0.8
PCS Scores
Baseline PCS score > 1 standard deviation 
above age/gender norms
10.0%
Within 1 standard deviation of age/gender 
norms
63.7%
>1 standard deviation below age/gender 
norms
17.9%
>2 standard deviation below age/gender 
norms
8.5%
* Diabetes, coronary artery disease, congestive heart failure, 
musculoskeletal disease, respiratory disease and depression.
** From a list of 16 additional conditions.
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Subjects with CHF, diabetes or chronic respiratory disease
had increased odds of a clinically significant decline in
PCS over 4 years. These odds ratios (confidence intervals)
were 2.9 (1.7, 5.0), 2.1 (1.5, 2.9) and 1.7 (1.1, 2.8) respec-
tively (Table 3). Subjects with diagnoses of CAD,
musculoskeletal disease, or depression did not show a sig-
nificant change in physical well being over 4 years relative
to the referent population. The effects of these main con-
ditions on physical well being over 4 years were con-
firmed by the linear model in which subjects with
diagnoses of CHF, diabetes or respiratory disease had
adjusted 4-year declines in PCS scores of -10.0, -3.2 and -
3.1 points (p < = 0.05 for all).
An absolute decrease in PCS of 6.5 points per subject was
used as criteria for a clinically significant decline in PCS
over time based on previous analyses of the MOS data and
on validation of the SF-36® survey instrument [17]. The
linear regression model presents changes in PCS for the
population of subjects adjusted for characteristics of that
population. Therefore the statistically significant changes
in PCS scores over time resulting from the linear
regression analysis may not necessarily be greater than 6.5
points
Little increase in the odds of functional decline was evi-
dent in individuals with 1,2, or 3 of the main chronic con-
ditions. However having 4 or more of these conditions
predicted a decline in PCS (OR 2.8; CI 1.3, 5.9) (Table 4
and Figure 1). The effect on PCS of the number of chronic
diseases was similar in older and younger age groups.
Discussion
Physical well being is particularly relevant for persons
with chronic conditions and the clinicians who care for
them. Declines in physical well being may have signifi-
cant social, emotional and economic repercussions, as
they correlate with job loss, high health care utilization
and increased mortality [20]. Based on this analysis of a
heterogeneous population from the MOS; persons with
CHF, diabetes and/or chronic respiratory disease are at
particular risk. Primary care providers are in an ideal posi-
tion to help prevent, delay or proactively manage poten-
tial declines in physical functioning for these patients.
Table 3: Adjusted odds of a decline in PCS attributable to presence vs. absence of each main chronic diseasea (Total N = 1574)
Disease Nb Adjusted odds ratio
Hypertension 281 1.0
Diabetes 249 2.1 (1.5, 2.9)
Coronary Artery Disease 364 1.1 (0.8, 1.5)
Congestive Heart Failure 137 2.9 (1.7, 5.0)
Respiratory Disease 125 1.7 (1.1, 2.8)
Musculoskeletal Disease 514 0.9 (0.7, 1.2)
Depression 319 1.3 (0.9, 1.8)
a) Adjusted for number of main conditions, number of additional comorbid conditions, poverty level, gender, race, educational level, employment 
status, marital status.
b) Sum to more than 100% due to coexisting conditions
Table 4: Number of main chronic conditions as predictors of a decline in physical well being over four years
Number of main chronic conditions N Adjusted odds of a decine in PCSab (N = 
1574)
Hypertension alone 281 1.0
One main chronic diseasec 607 1.1 (0.8, 1.4)
Two main chronic diseasesc 423 1.2 (0.8, 1.7)
Three main chronic diseasesc 197 1.4 (0.9, 2.2)
Four or more chronic diseasesc 66 2.8 (1.3, 5.9)
a) Adjusted for age, number of additional comorbid conditions, poverty level, gender, race, educational level, employment status, marital status.
b) Number of main chronic diseases as a predictor of a decrease in PCS is statistically significant at p < = .05
c) Subjects with one, two, three or four or more of the following: DM, CAD, CHF, musculoskeletal disease, respiratory disease, or depression. May 
also include hypertension.
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In this analysis of change in physical well being over time
in persons with a variety of chronic medical conditions,
we found that specific diagnoses of CHF, diabetes and/or
chronic respiratory disease; or the presence of 4 or more
chronic conditions, were predictive of a clinically signifi-
cant decline in PCS. We hypothesize that our findings
reflect the different clinical courses of each of these condi-
tions as well as the varying potential for therapeutic inter-
ventions in each case. The natural history of CHF, diabetes
and some respiratory disease is progressive. Treatment of
these conditions is aimed at optimizing long-term health
outcomes. Ongoing management involves self-care that is
replete with complex concepts and tasks. In contrast,
management of CAD and musculoskeletal disease may
include the potential for surgical intervention and proto-
col-driven rehabilitation programs. While some sub-pop-
ulations of patients with these latter conditions may
develop increasing disability, others may experience sig-
nificant improvement in physical well being over time.
For example, increases in PCS scores associated with hip
replacement and therapy for low back pain can be in the
range of 9.5 and 7.6 respectively [20]. We have no specific
information on such interventions in our study popula-
tion and therefore were unable to incorporate treatment
interventions into our analysis.
Disease management programs have been successful in
improving health outcomes for persons with these and
other chronic conditions [25,26]. However these pro-
grams are often disease specific [4,27,28]. As this study
population illustrates, many chronic conditions do not
occur in isolation. This may make disease-specific pro-
grams less beneficial for many patients. Some compo-
nents of successful disease-management programs that
are particularly relevant to persons managing multiple
medical conditions include: guidance in problem solving,
decision making, confidence building, self-management
support, and systematic support of the disease manage-
ment process [29-31].
In considering the issue of functional decline, any 'clini-
cally significant change' over time is not only a function
the starting and ending levels of functional status. It also
is determined by the individual for whom the change has
meaning, the instrument used to assess the change, and
population norms that provide the context for the
observed change [32,33]. Population-based studies
(including ours) address parts of this equation, but do not
address the most important dependent variable in the
equation: the implications of a change in function to the
individual. It is up to the provider and the patient to inter-
pret the 'data' in the context of the individual and con-
sider any subsequent recommendations in that same
context.
Our findings on depression deserve special mention.
Depression in particular and mental health in general are
well known to affect the management and outcomes of
several chronic medical conditions [34-36]. Furthermore
there is a high prevalence of coexisting depression in per-
sons with chronic disease [37]. In this analysis, we found
that depression did not predict a decline in physical func-
tioning over time. We hypothesize that this is partly due
to the natural history of the disease: Depression has a wax-
ing and waning course, and disease symptoms that are
subject to significant environmental and social effects.
Therefore the effect of depression on physical functioning
in this patient population may have varied significantly
within the population over time. Our findings are also
consistent with previous findings on depression in this
data set: When MOS subjects with depression were fol-
lowed over two years [12], they were noted to have similar
or improved scores of physical functioning at the end of
two years relative to those at baseline. It is possible that
this trend continued in our sub-sample and accounted for
the non-significant change in PCS score for subjects with
depression as a comorbid condition.
The study of comorbidity is, by definition, the study of
inter-relationships: between different diseases and
between diseases and age or other health-related sociode-
mographic variables. Caring for persons with chronic ill-
ness is, similarly, the care of heterogeneous populations
of individuals with multidimensional medical, psycho-
logical and social issues. The heterogeneity of this study
population may be relevant to the provider willing to sac-
rifice some internal validity in hopes of generalizing the
findings to his or her patient population.
Change in PCS relative to hypertension alone by number of main chronic dis asesFigur 1
Change in PCS relative to hypertension alone by number of 
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Limitations
Our sample size precluded stratification to investigate the
relative contributions of different medical conditions to
physical well being in sub-populations defined by specific
combinations of conditions, smaller age groups, socioe-
conomic status or other demographic criteria that might
further clarify the interactive nature of the comorbid
chronic disease process. It is likely that the effect of CHF,
diabetes, chronic respiratory disease or other conditions
on measures of health related quality of life differs within
different subpopulations. Specifically, vulnerable popula-
tions may be more at risk of poor health outcomes due to
socioeconomic status or process of care factors than spe-
cific disease states [17,38]. In addition, there may be addi-
tional psychological and sociodemographic factors (e.g.
levels of self-efficacy and social support systems) that we
were unable to incorporate in our model, which affect
outcomes in persons with comorbid conditions. In the
original MOS cross-sectional analysis of functional status
and well being, most of the variance in outcomes meas-
ured (including PCS scores) was not attributable to the
diseases studied the same is true of our longitudinal anal-
ysis [16].
Due to the nature of the MOS data base, we compared the
effect of selected chronic conditions on physical well
being to a referent group with hypertension alone. While
the effect of hypertension alone on physical well being
over 4 years may be minimal ; it is possible that there is a
synergistic effect between hypertension and certain condi-
tions such as CAD and CHF on physical well being over
time. If so, the effect of CAD or CHF on PCS scores for per-
sons with these conditions may have been slightly magni-
fied. It is unlikely that this bias would change the overall
significance of the results of our analysis.
We were unable to directly account for severity of illness
for all main chronic conditions either at baseline or fol-
low-up. However statistical adjustments for starting PCS
score relative to age/gender norms and the inclusion of
patients who died in the final analysis should indirectly
account for some degree of severity of illness throughout
the study population.
As in all investigations, the conclusions reflect the popu-
lation studied: primarily Caucasian, with a majority above
200% of the federal poverty level, relatively well educated
and specifically selected for inclusion on the basis of cer-
tain medical diagnoses. Results from this study may not
be generalizable to populations with different demo-
graphic characteristics and different constellations of
comorbid conditions.
Conclusions
This analysis suggests that long term physical well being in
persons with multiple chronic diseases is a function of
both the number and type of medical conditions. Relative
to persons with hypertension alone, those who carry diag-
noses of CHF, diabetes and chronic respiratory disease
have an increased risk of a decline in physical well being
over 4 years. The presence of CAD, musculoskeletal dis-
ease or depression does not predict a similar decline.
For the primary care physician for whom 'comorbidity'
implies an exponentially increasing ratio of items on the
problem list to available time during the office visit, the
specific diagnoses of CHF, diabetes and chronic respira-
tory disease may serve as triggers for management deci-
sions. Clinicians who care for patients with these
common conditions should be alert to the possibility that
a proactive approach incorporating generalizable princi-
ples of disease management may either attenuate this loss
of function or help the patient and family anticipate
future needs.
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